Figure 4.
Probability of progression-free survival with respect to Fd/Bu/ATG versus other regimens in 118 patients who received transplants in first chronic phase.
Probability of progression-free survival with respect to Fd/Bu/ATG versus other regimens in 118 patients who received transplants in first chronic phase.
